Japan’s Fujitsu Limited unveiled an artificial intelligence platform designed to streamline healthcare operations, joining the growing list of technology companies betting on the sector’s AI transformation. The system features what Fujitsu calls an “orchestrator AI agent” that coordinates multiple specialized healthcare applications.
Fujitsu reported consolidated revenues of ¥3.6 trillion ($23 billion) for the fiscal year ended March 31, 2025, positioning the company as Japan’s largest digital services firm by market share. The healthcare platform leverages Nvidia’s NIM microservices and Blueprints technology, extending the companies’ existing partnership on Japan’s next-generation FugakuNEXT supercomputer.
Healthcare organizations face mounting skepticism about AI implementations, with 83% of US consumers viewing AI’s potential for error as a barrier and 86% expressing transparency concerns, according to recent market research. About 90% of AI/ML projects fall short of achieving return on investment due to misaligned priorities and tools, Forbes reported.
The announcement comes as the global AI healthcare market size was estimated at $26.57 billion in 2024 and is projected to reach $187.69 billion by 2030. Fujitsu plans to commercialize the platform in 2025 through partnerships with medical institutions worldwide, though the company provided no financial projections or implementation timelines for the initiative.
